Clinical pharmacology of 9-aminocamptothecin.
Takimoto
C H
CH
NCI-Navy Medical Oncology Branch, Bethesda Naval Hospital, Maryland 20889, USA.
Dahut
W
W
Harold
N
N
Nakashima
H
H
Lieberman
R
R
Liang
M D
MD
Arbuck
S G
SG
Chen
A P
AP
Hamilton
J M
JM
Cantilena
L R
LR
Allegra
C J
CJ
Grem
J L
JL
D000328:Adult; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D059004:Topoisomerase I Inhibitors
D000970:Antineoplastic Agents; D059004:Topoisomerase I Inhibitors; C080125:9-aminocamptothecin; D002166:Camptothecin